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2Abbreviations: Reactive Oxygen Species (ROS). Photodynamic Therapy (PDT). Gold Nanoparticles (GNP). 
Singlet Oxygen (
1
O
2
). Photosensitisers (PS). Dynamic Light Scattering (DLS). High-Resolution Transmission 
Electron Microscopy (HRTEM). Dimethyl sulfoxide (DMSO). Methanol (MeOH). Dimethylformamide (DMF). 
Gold (III) chloride trihydrate (HAuCl
4
·3H
2
O). Methyl imidazole (Im-C
1
). Octadecylimidazole (Im-C
18
). Sodium 
borohydride (NaBH
4
). 1-(11-Mercaptoundecyl)imidazole (Im-C
11
-SH). (11-Mercaptoundecyl)hexa(ethylene glycol) 
(HS-C
11
-(EG)
6
-OH). Sodium chloride (NaCl). Sodium phosphate monobasic (NaH
2
PO
4
). Fetal Bovine Serum (FBS). 
9,10-Anthracenediyl-bis(methylene)dimalonic acid (ABMA). Potassium chloride (KCl). Calcium chloride dihydrate 
(CaCl
2
∙2H
2
O). Magnesium chloride hexahydrate (MgCl
2
∙6H
2
O). 4-(2-Hydroxyethyl)piperazine-4-ethanesulfonic acid 
(HEPES). Bovine Serum Albumin (BSA), Sodium phosphate dibasic (Na
2
HPO
4
), Potassium phosphate monobasic 
(KH
2
PO
4
). Ethylenediaminetetraacetic acid (EDTA). L-glutamine (L-Gln). Human breast adenocarcinoma cells (SK-
BR-3). Hank’s Balanced Salt Solution (HBSS). Phosphate buffered saline (PBS). Zn(II)-meso-tetraphenylporphyrin 
(ZnTPP). Zn(II)meso-tetrakis(4-carboxyphenyl)porphyrin, sodium salt (Na-ZnTCPP). Tetrakis(4-
carboxyphenyl)porphyrin, sodium salt (Na-H2TCPP). 
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Hypothesis 
Metalloporphyrins are extensively investigated for their ability to form reactive oxygen species 
and as potent photosensitisers for use in photodynamic therapy. However, their hydrophobicity 
generally causes solubility issues concerning in vivo delivery due to lack of distribution and low 
clearance from the body. Immobilising porphyrins on carriers, such as gold nanoparticles (GNP), 
can overcome some of these drawbacks. The mode of assembling the porphyrins to the carrier 
influences the properties of the resulting drug delivery systems. 
Experiments 
We describe the synthesis and characterisation of new porphyrin decorated water soluble GNP 
and we explore Zn-imidazole axial coordination as the mode of linking the porphyrin to the 
metallic core of the nanoparticles. Quantification of singlet oxygen production, toxicity in dark, 
cellular uptake by SK-BR-3 cells and phototoxicity have been assessed. 
Findings 
Axial coordination limits the number of porphyrins on the gold surface, reduces the formation of 
aggregates, and diminishes metal exchange in the porphyrin, all of which contribute to enhance 
the efficiency of singlet oxygen generation from the immobilised porphyrin. In vitro experiments 
on SK-BR-3 cells reveal a fast uptake followed by more than 80% cell death after irradiation 
with low doses of light. 
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1. Introduction 
Porphyrins have been increasingly studied due to their numerous applications in different 
areas such as photochemistry, molecular recognition, sensors, molecular machines or in 
photodynamic therapy (PDT).
1–3
 The presence and the nature of a central metal ion influences 
the photophysical properties of metalloporphyrins and can lead, as is the case for PDT, to an 
increased production of reactive oxygen species (ROS) and singlet oxygen (
1
O2) due to the 
heavy-metal effect.
4
 However, the majority of photosensitisers (PS) used in PDT are 
hydrophobic, which generally raises solubility concerns when applied in the clinical setting, 
causing poor biodistribution and low clearance from the body.
5 
Therefore, the use of 
nanostructured vehicles to transport and deliver such PS can help to overcome this limitation. 
Nanoparticles are envisaged as powerful platforms for molecular recognition
6
 and they have 
been used for cancer theranostics following porphyrin coating.
7
 Amongst others, gold 
nanoparticles (GNP) have been explored as drug delivery carriers for PDT,
8–10
 and they offer an 
added value since porphyrins are more effective when immobilised on GNP rather than free in 
solution, showing enhanced 
1
O2 production.
10–12
 Different parameters influence the 
1
O2 
generation efficacy of immobilised porphyrins, such as the particle size, the length of the linker, 
their surface density and their orientation with respect to the gold core.
13–16
 For instance, the 
fluorescence quantum yield decreases when the average number of coating porphyrins 
increases.
13,14
 The majority of the examples reported in the literature
7,13
 and by us
9,11,17,18
 
describe the self-assembly of thiolated porphyrins onto GNP through synthetic approaches that 
do not enable a complete control of the surface density and localisation of the coating agents, 
especially when mixed monolayers are used.  
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Immobilisation of metalloporphyrins in a well-defined orientation on the GNP surface could 
bring control to the assembly and improve PDT properties of the nanomaterial. Axial base 
coordination to metalloporphyrins has been extensively used for the design of self-assembled 
materials,
19
 an interaction exploited at the base of some sensors.
20
 Here, we explore axial base 
coordination as the mode of linkage between metalloporphyrins and GNP surfaces. Thus, we 
designed a multicomponent self-assembled material, the components of which offer different 
functions and advantages, contributing to improved PDT properties. This multifunctional new 
water-soluble nanomaterial (Na-ZnTCPPImGNP) is formed by a) GNP as the carrier core and 
as a singlet oxygen generation enhancer, b) a water-soluble Zn-porphyrin as an efficient 
photosensitiser, capable of axial coordination, c) a thiolated imidazole derivativeas the stabiliser 
agent of gold and the linker to the Zn-porphyrin, of sufficient length (11 carbon atoms spacer) to 
avoid gold-porphyrin direct interaction, and d) a thiolated polyethyleneglycol co-coating agent, 
to increase the water solubility of the whole system. We expected that this specific spatial 
disposition would limit the number of porphyrins on the gold surface,
13
 reduce the formation of 
aggregates
21,22
 and reduce the possibility of metal exchange of the porphyrin,
22
 contributing to an 
enhancement in the efficiency of 
1
O2 generation beneficial for PDT.  
Different techniques were used to characterise the novel Na-ZnTCPPImGNP including UV-
visible absorption spectroscopy, dynamic light scattering (DLS), high-resolution transmission 
electron microscopy (HRTEM) and fluorescence spectroscopy. Several parameters regarding the 
GNP were investigated, such as the amount of the incorporated photosensitiser, the production of 
1
O2 and the PDT activity of the nanosystems. The PDT activity was investigated in vitro using 
SK-BR-3 human breast adenocarcinoma cells by studying cytotoxicity, phototoxicity and 
intracellular uptake, to provide a water-soluble nanosystem suitable for PDT. 
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2. Experimental Section 
2.1. Materials 
Solvents 
Dimethyl sulfoxide (DMSO), methanol (MeOH), dimethylformamide (DMF) and toluene were 
purchased from Sigma Aldrich. 
Reagents 
Gold (III) chloride trihydrate (HAuCl4·3H2O), methyl imidazole (Im-C1), octadecylimidazole 
(Im-C18) and sodium borohydride (NaBH4) were obtained from Sigma-Aldrich (Germany). 1-
(11-Mercaptoundecyl)imidazole (Im-C11-SH) and (11-mercaptoundecyl)hexa(ethylene glycol) 
(HS-C11-(EG)6-OH) were purchased from Prochimia (France). Sodium chloride (NaCl), sodium 
phosphate monobasic (NaH2PO4) and fetal bovine serum (FBS) were purchased from Thermo 
Fisher Scientific (UK). 9,10-Anthracenediyl-bis(methylene)dimalonic acid (ABMA), potassium 
chloride (KCl), calcium chloride dihydrate (CaCl2∙2H2O), magnesium chloride hexahydrate 
(MgCl2∙6H2O), 4-(2-hydroxyethyl)piperazine-4-ethanesulfonic acid (HEPES), bovine serum 
albumin (BSA), sodium phosphate dibasic (Na2HPO4), potassium phosphate monobasic 
(KH2PO4) and propidium iodide were purchased from Sigma-Aldrich (UK). Trypsin 0.25% with 
ethylenediaminetetraacetic acid (EDTA) and McCOY’s 5A phenol red-free medium containing 
L-glutamine (L-Gln) were purchased from Invitrogen (UK). CellTiter-Blue cell viability assay 
was purchased from Promega (UK). 75 cm
2
 Nunc Easy tissue culture flasks with porous caps, 
Nunc Nunclon
TM
 Surface 6-well multidishes, Nunc Nunclon
TM
 Surface 96-well white-bottom 
microplates and 18 mm diameter glass coverslips were purchased from Thermo Fisher (UK). 
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SK-BR-3 human breast adenocarcinoma cells were purchased from LGC Standards and kindly 
provided by Prof Dylan R. Edwards (Norwich Medical School, University of East Anglia, UK). 
2.2. Characterisation methods 
UV-visible absorption spectra were obtained using a UV-1800 Shimadzu UV 
spectrophotometer. The samples were placed in quartz cuvettes with a 1 cm path length. 
Absorption spectra were determined in toluene or water. Fluorescence excitation and emission 
spectra were recorded using a Hitachi F-4500 fluorescence spectrometer. The spectra were 
recorded using quartz cuvettes with a 1 cm path length. High-Resolution Transmission Electron 
Microscopy (HRTEM) images were obtained using a JEOL JEM 2100 transmission electron 
microscope at 200 kV from Centres Científics i Tecnològics Universitat de Barcelona (CCiT-
UB). The images were captured by a Megaview III Soft Imaging System camera and the size of 
the gold nanoparticles was measured with ImageJ. The size of the nanoparticles was also 
determined by Dynamic Light Scattering (DLS) using a Zetasizer Nano ZS series (Malvern 
Instruments). Thermogravimetric analysis (TGA) was performed on Mettler Toledo TGA/SDTA 
851e, from 30 °C to 700 °C with a heating rate of 5 °C min
-1
, from CCiT-UB. Capsules: crucible 
of aluminium (100 µL) with perforated cap. Nitrogen was used as purgative gas in all of the 
measurements. SK-BR-3 cells were imaged using a Zeiss Axiovert 200M microscope. 
Fluorescence images were captured using a 63x PlanApochromat (1.4 NA) oil-immersion 
objective lens, a Zeiss AxioCamMRm CCD camera and AxioVision software. Images were 
collected and processed using the AxioVision SE64 Rel. 4.8 software. 
2.3. Synthesis and characterisation of Na-ZnTCPPImGNP 
A solution of HAuCl4·3H2O (3.6 mg, 0.009 mmol) in water (1.0 mL) was added to a stirred 
solution of 11-mercaptoundecyl hexa(ethylene glycol) (HS-C11-(EG)6-OH) (4.2 mg, 
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0.008 mmol) and thiol-imidazole Im-C11-SH (6.9 mg, 0.027 mmol) in MeOH (2.0 mL). Then, an 
excess of NaBH4 (5.3 mg, 0.14 mmol) in water (1.0 mL) was added dropwise to the mixture, 
while the solution changed to a dark red colour. The reaction was allowed to occur under stirring 
at room temperature overnight. After this time, the residue containing the ImGNP was washed 
with water (3x5mL) by centrifugation (14,500 rpm, 15 min at 15 °C, LabnetPrismR centrifuge). 
A brown solution was obtained as ImGNP, which was characterised by UV-visible absorption 
spectroscopy and HRTEM. Then, a solution of ImGNP (1 mL, 7.1×10
-3
 µM) in water was added 
to an aqueous solution of Na-ZnTCPP (1.6 ×10
3
 µM) and the mixture was stirred at room 
temperature overnight. The residue, containing the Na-ZnTCPPImGNP, was washed with 
water (3x5mL) by centrifugation (14,500 rpm, 15 min at 15 °C, LabnetPrismR centrifuge). The 
purified nanoparticles Na-ZnTCPPImGNP were characterised by UV-visible absorption and 
fluorescence spectroscopies, and HRTEM.  
2.4. Singlet oxygen production of the Na-ZnTCPP and Na-ZnTCPPImGNP 
Singlet oxygen production was measured using the singlet oxygen probe 9,10-anthracenediyl-
bis(methylene)dimalonic acid (ABMA). ABMA is photobleached in the presence of 
1
O2 to give a 
non-fluorescent 9,10-endoperoxide product. The photobleaching can be monitored by 
fluorescence spectroscopy. A solution of ABMA (0.2 mg, 0.51 mM) in MeOH (1 mL) was 
prepared. Then 3 μL of this solution was added to a quartz cuvette containing either Na-
ZnTCPP (4.34 μL, 3 μM) or Na-ZnTCPPImGNP (484 μL, 3 μM of incorporated porphyrin) in 
water. The final volume (1.5 mL) in the cuvettes was completed with water and the solutions 
were thoroughly stirred. A light source in the range 400-500 nm was used to irradiate the 
mixtures during 4 h, using a power of 0.16 mW/cm
2
. The light source was located 3 cm away 
from the cuvette. Fluorescence emission spectra were recorded every hour between 390-600 nm, 
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following excitation at 380 nm. Singlet oxygen production was determined by the decrease of the 
fluorescence emission intensity of ABMA at 431 nm. 
2.5. Biological experiments 
Imaging medium 
The imaging medium based on Hank’s balanced salt solution (HBSS) used for the biological 
experiments was prepared in water containing NaCl (120 mM), KCl (5 mM), CaCl2∙2H2O 
(2 mM), MgCl2∙6H2O (1 mM), NaH2PO4 (1 mM), NaHCO3 (1 mM), HEPES (25 mM), D-
glucose (11 mM) and BSA (1 mg/mL). The pH of the imaging medium was adjusted to 7.4 using 
an aqueous solution of NaOH (1 M). The imaging medium was sterilised-filtered through a 
Millex GP syringe driven filter unit (0.22 µm) prior to use. 
Phosphate buffered saline (PBS) 
The PBS solution used for the biological experiments was prepared by dissolving 10 PBS 
tablets in water (1 L). The solution was sterilised by autoclaving at 110 °C for 10 min. The 
newly prepared PBS solution contained Na2HPO4 (8 mM), KH2PO4 (1 mM), NaCl (160 mM) 
and KCl (3 mM) with a pH value of 7.3. 
Propidium iodide solution in PBS 
A solution of propidium iodide (1 mg/mL) was prepared in PBS. The PBS buffer (10 mM) 
used was prepared using NaH2PO4∙2H2O and Na2HPO4 stock solutions (200 mM). The PBS 
solution contained NaCl (150 mM) and CaCl2∙2H2O (100 μM). The pH of the PBS was adjusted 
to 7.4 using aqueous solutions of NaOH (1 M) and HCl (0.6 M). Prior to use, the propidium 
iodide solution was sterilised by filtration through a 0.22 μm filter unit. 
Culture of SK-BR-3 cells 
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SK-BR-3 cells were routinely cultured in phenol red-free McCOY’s 5A medium containing 
L-Gln and supplemented with FBS (10%). The cells were grown in 75 cm
2
 Nunc Easy tissue 
culture flasks at 37 °C under a 5% CO2 atmosphere. SK-BR-3 cells were subcultured (1:4) every 
5 days, when they reached near confluence. The culture medium was discarded and the cells 
were washed with PBS (5 mL). The cells were dislodged from the flasks by addition of trypsin 
0.25% (1x) EDTA (5 mL) and incubation for 5 min at 37 °C under a 5% CO2 atmosphere. 
Trypsin was deactivated by addition of McCOY’s 5A medium (5 mL) and removed by 
centrifugation at 800 rcf for 5 min at 21 °C using an Eppendorf 5810R Centrifuge. The 
supernatant was removed and the pellet containing the cells was resuspended in McCOY’s 5A 
medium (8 mL) and transferred to two 75 cm
2
 culture flasks. 
CelTiter-Blue® cell viability assay 
The SK-BR-3 cells were seeded on a white-bottom Nunc Nunclon
TM
 ∆ Surface 96 well 
multidish at a density of 8×10
4
 cells per well in phenol red-free McCOY´s 5A medium 
containing FBS (10%) and L-Gln. The cells were incubated for 48 h at 37 °C under a 5% CO2 
atmosphere. The medium was then removed and the cells were washed once with PBS (100 µL). 
The cells were incubated with Na-ZnTCPPImGNP at either 1.5 μM or 1.75 μM of incorporated 
porphyrin in FBS-free, phenol red-free McCOY´s 5A medium (50 μL) containing L-Gln for 3 h 
at 37 °C under a 5% CO2 atmosphere. Additionally, a solution of Staurosporine (1 mM in 
DMSO) dispersed in FBS-free, phenol red-free McCOY’s 5A medium containing L-Gln (50 μL; 
20 μM) was used as a positive control for cytotoxicity. Following incubation, the medium was 
removed and the cells were washed three times with PBS (100 µL) to remove all non-
internalised GNP. The cells were kept in phenol red-free McCOY´s 5A medium (100 μL) 
containing FBS (10%) and L-GLn. At this point, some of the cells were irradiated using a light 
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source with a power of 2.54 mW/cm
2
 and an excitation wavelength between 400 and 500 nm. 
The cells were irradiated for 10, 20 or 30 min per well. The light source was located 1 cm above 
the 96 well plates. The wells not being irradiated were left covered with aluminum foil so that 
the light would not affect them. Once all the wells were irradiated, the cells were further 
incubated for 48 h at 37 °C under a 5% CO2 atmosphere. CellTiter-Blue® reagent (20 µL) was 
added to each well and incubated for 4 h at 37 °C under a 5% CO2 atmosphere. Fluorescence 
emission intensity in the wells was then measured at 590 nm following excitation at 560 nm 
using a CLARIOstar® (BMG Labtech) microplate reader. Background fluorescence was 
corrected by subtracting the fluorescence emission of phenol red-free McCOY´s 5A medium 
incubated with CellTiter-Blue®. Cell viability was calculated as a percentage of non-treated, 
non-irradiated cells. The samples were analysed in triplicate. Control cells without Na-
ZnTCPPImGNP loaded were treated with FBS-free, phenol red-free McCOY’s 5A medium 
during the 3 h incubation period. Furthermore, control cells were only irradiated for 30 min to 
assess the direct effect of the blue light source on the cells.  
Treatment of SK-BR-3 cells to study internalisation and PDT effect of Na-ZnTCPPImGNP 
For imaging, SK-BR-3 cells were cultured on sterile 18 mm diameter glass coverslips inside 
Nunc 6-well multidishes at a density of 2×10
4
 cells/mL (3 mL/well) at 37 °C under a 5% CO2 
atmosphere 48 h prior to performing imaging experiments. 
The growth medium of the SK-BR-3 cells on the coverslip was removed. The cells were then 
washed with PBS (1 mL) once. For samples treated with the Na-ZnTCPPImGNP, a solution of 
the Na-ZnTCPPImGNP (1 mL) in FBS-free, phenol red-free McCOY’s 5A medium containing 
L-Gln at either 1.5 μM or 1.75 μM was added to the coverslip. For control cells, FBS-free, 
phenol red-free McCOY’s 5A medium containing L-Gln (1 mL) was added to the coverslip. The 
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cells were then incubated for 3 h at 37 °C under a 5% CO2 atmosphere. Following incubation, 
the cells were washed three times with PBS (1 mL) and kept in phenol red-free McCOY’s 5A 
medium containing FBS (10%) and L-Gln (2 mL). 
At this point, some of the cells were irradiated using the light source (400 – 500 nm) with a 
power of 2.54 mW/cm
2
 for 30 min per well. The light source was located 1 cm above the plates. 
The wells not being irradiated were left covered with aluminum foil so the light would not affect 
them.  All the cells the cells were further incubated for ca. 72 h at 37 °C in a 5% CO2 
atmosphere. 
Imaging of SK-BR-3 cells using a fluorescence microscope 
For imaging, the 18 mm coverslip containing the SK-BR-3 cells was placed in a Ludin 
chamber (Life Imaging Service, Olten, Switzerland), which was securely tightened. Each 
coverslip was washed three times with imaging medium (ca. 1 mL) and finally resuspended in 
imaging medium (ca. 1 mL). The Ludin chamber was fitted on a heating stage at 37 °C in a Zeiss 
Axiovert 200M fluorescence microscope. The images were acquired with a 63x Plan 
Apochromat (1.4 NA) oil-immersion objective. Na-ZnTCPPImGNP internalised by the cells 
were excited at 530-585 nm and the fluorescence emission was collected in the red channel 
through a 600 nm long-pass filter. To evaluate the PDT effect, propidium iodide (5 μL, 1 mg/mL 
in PBS) was mixed with imaging medium (1 mL). The solution was directly added to the 
coverslip already placed in the Ludin chamber and incubated at 37 °C in the dark on the heating 
stage of the fluorescence microscope for ca. 5 min. The propidium iodide was excited at 530-
585 nm and the fluorescence emission was collected in the red channel through a 600 nm long-
pass filter. 
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3. Results and Discussion 
The structures of the porphyrins used in this work are shown in Fig. 1a, and they were 
synthesised following protocols previously reported.
23–27
 An imidazole based ligand for axial 
coordination was selected, because imidazole derivatives bind more strongly than pyridine 
derivatives to Zn-porphyrins.
28–30
 In order to select the optimum components to be used in the 
subsequent preparation of Na-ZnTCPPImGNP exploiting axial coordination, the complexation 
in solution was evaluated between the model porphyrin ZnTPP (in toluene) or Na-ZnTCPP (in 
water) and different alkylimidazoles: methyl imidazole (Im-C1), 1-(11-
mercaptoundecyl)imidazole (Im-C11-SH) and octadecylimidazole (Im-C18) (Fig. 1b). The 
complexation study was analysed using UV-visible absorption spectroscopy and the results (as 
seen in ESI Fig. S1-S3) were in agreement with previously reported data
19,28-30
 and confirmed the 
coordinationability between the central Zn atom in both porphyrins and the different imidazole 
derivatives. Also, the titration experiments in aqueous solution revealed that there is no 
significant influence of the chain length of the imidazole connector upon coordination to Na-
ZnTCPP. Subsequently, the sodium salts of porphyrins tetrakis(4-carboxyphenyl)porphyrin 
(Na-H2TCPP) and Zn(II)meso-tetrakis(4-carboxyphenyl)porphyrin (Na-ZnTCPP) were used as 
photosensitisers and were immobilised on water-soluble nanoparticles. 
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Fig. 1. Structures of: a) Porphyrins ZnTPP, Na-H2TCPP and Na-ZnTCPP, b) imidazole 
derivatives (Im-C
1
, Im-C
11
-SH and Im-C
18
) and c) schematic representation of Na-
ZnTCPPImGNP. 
3.1. Synthesis and characterisation of Na-ZnTCPPImGNP 
Taking into account the coordination results, where the ability of the Im-C11-SH to coordinate 
with Na-ZnTCPP was proven, the possibility to incorporate Na-ZnTCPP into imidazole 
modified ImGNP was tested.  
Im-C11-SH was chosen to be integrated in the Na-ZnTCPPImGNP (Fig. 1c) due to its high 
affinity for the metalloporphyrin of interest.
19,31,32
 The thiol group present in the Im-C11-SH 
allows assembly to the gold surface of the GNP, facilitating their synthesis, stabilisation and 
subsequent incorporation of the photosensitiser Na-ZnTCPP upon axial coordination. Imidazole 
functionalised gold nanoparticles ImGNP were synthesised using a mixture of thiols HS-C11-
(EG)6-OH and Im-C11-SH as the stabilising agents; the thiol HS-C11-(EG)6-OH provides water 
solubility and Im-C11-SH acts as the connector for the subsequent coordination of Zn-porphyrins. 
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The UV-visible absorption spectra of the ImGNP showed a strong absorption band at 
approximately 526 nm, originated from the surface plasmon absorption of nanosized GNP (Fig. 
2a red line). These ImGNP were characterised by high-resolution transmission elctron 
microscopy (HRTEM) to study their morphology and size distribution as seen in ESI Fig. S4a; 
ImGNP displayed a cubeoctahedron shape and a low polydispersity with an average size of 8 
nm (ESI Fig. S4a and c). Then, the synthesis of Na-ZnTCPPImGNP was carried out by mixing 
ImGNP and Na-ZnTCPP in water. Na-ZnTCPPImGNP were characterised by UV-visible 
absorption spectroscopy (Fig. 2a blue line). The absorption spectrum of Na-ZnTCPPImGNP 
exhibited the surface plasmon band of GNP at ca. 520 nm andthe porphyrin Soret band at ca. 
430 nm. The Soret band of the Na-ZnTCPP coordinated to the gold nanoparticles is red-shifted 
compared to that of the free Na-ZnTCPP (λ = 420 nm; Fig. 2a black line) due to the 
coordination between the Zn-porphyrin and the imidazole moieties on the GNP. In addition, the 
UV-visible absorption spectrum of the Na-ZnTCPPImGNP shows an indication of the presence 
of the two typical zinc porphyrin Q bands at 564 and 608 nm. Furthermore, Na-
ZnTCPPImGNP display a cubeoctahedron shape and a low polydispersity with an average size 
of 8 nm as shown in Fig. 2b and in ESI Fig. S4b and d.  
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Fig. 2. a) UV-visible absorption spectra of the free porphyrin Na-ZnTCPP (black line), ImGNP 
(red line) and Na-ZnTCPPImGNP (blue line) recorded in water and b) HRTEM image of Na-
ZnTCPPImGNP. 
 
The size of ImGNP and Na-ZnTCPPImGNP was also measured using dynamic light 
scattering (DLS). Both types of nanoparticles proved stable in solution and have low 
polydispersity with an average hydrodynamic size between 13.5-15.4 nm. The nanoparticle 
diameter obtained by DLS is larger than that obtained by HRTEM. In HRTEM, only the size of 
the gold core was measured since no contrast agent was used and the surrounding ligands are 
transparent to the electron beam. On the contrary, DLS measures the hydrodynamic size of the 
nanoparticles. Therefore, the size measured by DLS gives the diameter that includes not only the 
core but also the alkyl chains of the ligands. Na-ZnTCPPImGNP showed the largest size (15.4 
nm), this result is likely due to the porphyrin coordinated with the imidazole Im-C11-SH on the 
surface of Na-ZnTCPPImGNP, which leads to an increase in the hydrodynamic diameter of the 
nanoparticles. 
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The fluorescence emission spectra of both Na-ZnTCPP and Na-ZnTCPPImGNP were 
recorded in water (see ESI Fig. S5), and both exhibited two emission bands at λ = 604 and λ = 
655 nm following excitation at 421 nm, as expected for Zn-porphyrin derivatives.
33
 In the case of 
the coated gold nanoparticles Na-ZnTCPPImGNP a decrease in the emission intensity with 
respect to the spectrum of the free porphyrin was observed, indicating the successful 
immobilisation of the porphyrin Na-ZnTCPP through axial coordination with the imidazole 
derivative on the GNP.
34
 
To differentiate axial coordination from unspecific immobilisation, we also synthesised 
nanoparticles using the porphyrin that did not contain zinc, Na-H2TCPP, yielding Na-
H2TCPPImGNP (see Section 2 in ESI). As shown in ESI Fig. S6a, the UV-visible extinction 
spectrum of the Na-H2TCPPImGNP shows a small band at 420 nm, corresponding to the 
incorporated Na-H2TCPP porphyrin, and showing no shift compared to the free Na-H2TCPP in 
solution. The incorporation of Na-H2TCPP onto ImGNP could be attributed to non-specific 
interactions such as those between the alkylimidazole coating and the porphyrin. Instead, the 
absorption spectrum of Na-ZnTCPPImGNP reveals an intense band at 430 nm due to the 
corresponding porphyrin Na-ZnTCPP axially incorporated (see ESI Fig. S6b), showing a red 
shift compared to the free Na-ZnTCPP in solution ( ca. 423 nm), which indicates that the 
porphyrin is located in a more hydrophobic environment as a consequence of a strong imidazole-
zinc coordination.
34
 This experiment demonstrates that the presence of the metal within the core 
of the porphyrin is essential for the axial coordination to the imidazole moiety linked to the 
GNP,
19,31,35,36
 thus facilitating the incorporation of the porphyrin on the GNP on a spatially 
controlled manner. 
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The amount of porphyrin, Na-H2TCPP or Na-ZnTCPP, per nanoparticle was estimated 
using UV-visible absorption spectroscopy (see ESI Fig. S6) and the calculations reported by 
Haiss et al.
37
 Using the extinction coefficient calculated for Na-H2TCPP (see ESI Fig. S7), the 
reported for Na-ZnTCPP
38
  and the concentration of GNP in the sample, a ratio of the porphyrin 
per nanoparticle can be estimated as shown in ESI Fig. S8 and Table S1, which shows all the 
data obtained from the UV-visible absorption spectra shown in ESI Fig. S6 that was used to 
estimate the ratio between the porphyrins and GNP. First, the absorbance at 420 nm (Na-
H2TCPP) or 430 nm (Na-ZnTCPP) corresponding to the porphyrins’ Soret band needs to be 
normalised to remove the influence from the GNP absorption spectrum. To calculate the 
contribution of the porphyrin ligands to the absorbance at 420 nm, the intensity corresponding to 
the GNP at 460 nm (Na-H2TCPPImGNP) or 480 nm (Na-ZnTCPPImGNP) should be 
subtracted from the total intensity at 420 nm or 430 nm, respectively. Secondly, Avogadro’s 
number, the volume per cuvette (3 mL) and the GNP diameter, which was previously obtained 
by HRTEM, can be used to calculate the number of porphyrin molecules per GNP (see ESI Fig. 
S8 and Table S1). 
The values shown in ESI Table S1 prompted us to calculate the number of porphyrin 
molecules immobilised on the Na-H2TCPPImGNP and Na-ZnTCPPImGNP, corresponding to 
186 Na-H2TCPP molecules/ GNP and 106 Na-ZnTCPP molecules/ GNP, respectively. A 
difference of the ratio of both immobilised porphyrins was obtained, indicating that the presence 
of the zinc on the porphyrin decreases the porphyrin incorporation due to its well-defined 
orientation associated to spatial constraints, including the contribution of the pegylated coating 
agent to steric hindrance, being its coordination with the imidazole moieties in the GNP what 
directs its ordered assembly around the gold core. 
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Additionally, thermogravimetric analysis (TGA) of Na-ZnTCPPImGNP was performed (s 
ee ESI Fig. S9) in an attempt to determine the presence of porphyrin into gold nanoparticles in 
more than one binding mode, due to the excess of porphyrin used in the synthesis of the gold 
nanoparticle, but the results are not conclusive, since the porphyrin used (Na-ZnTCPP) is a salt 
and a clear loss of mass is not expected to be seen clearly. The thermogram included in Fig. S9 
SI shows two main intervals of mass loss, probably corresponding to the loss of the two different 
thiolated species anchored on the gold surface. The second interval is quite wide because at this 
temperature range probably the porphyrin starts decomposing, so its mass loss is concomitant to 
the thiolated linker loss. 
3.2. Singlet oxygen production by Na-ZnTCPP and Na-ZnTCPPImGNP 
The singlet oxygen production of Na-ZnTCPP and Na-ZnTCPPImGNP was examined 
using anthracenediyl-bis(methylene)dimalonic acid (ABMA), a water-soluble anthracene 
derivative that reacts selectively with 
1
O2. Upon reaction with 
1
O2, ABMA is photobleached 
leading to the formation of a non-fluorescent 9,10-endoperoxide product.
17,38
 The reaction 
between ABMA and 
1
O2 can thus be monitored using fluorescence spectroscopy. The 
photosensitiser Na-ZnTCPP and the Na-ZnTCPPImGNP were irradiated, in the presence of 
ABMA, with a blue light source (400 – 500 nm), which excites the Soret band of the porphyrin 
(ca. 420 nm), for 4 h with continuous stirring. Fluorescence emission spectra were recorded 
every hour and the singlet oxygen production was determined by the decrease in the fluorescence 
intensity of ABMA at 431 nm (see ESI Fig. S10). Fig. 3a shows the percentage of 
photobleaching decay of ABMA at 431 nm following irradiation of the free Na-ZnTCPP (red 
line) and Na-ZnTCPPImGNP (blue line). As controls, the singlet oxygen production of 
ImGNP and ABMA were also monitored under the same conditions (see ESI Fig. S10) The 
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production of singlet oxygen by the ImGNP and by the ABMA probe was much lower than for 
the porphyrin containing nanoparticles (Fig. 3a, green and black line, respectively). These results 
confirm that the presence of the porphyrin photosensitiser is required to produce 
1
O2 upon 
irradiation. After a 4 hour irradiation period, the percentage of ABMA decay for Na-ZnTCPP 
was ca. 22% (Fig. 3, red line), while for the Na-ZnTCPPImGNP was ca. 56% (Fig. 3, blue 
line). The 
1
O2 production of the free porphyrin Na-ZnTCPP is lower than that of the 
corresponding functionalised Na-ZnTCPPImGNP, a feature observed previously for similar 
systems
10–12,17,38
 which may be attributed to the high localised plasmonic field generated in the 
gold surface that enhances ROS production.
10
 
To further compare the ability of both the free porphyrin Na-ZnTCPP and the functionalised 
Na-ZnTCPPImGNP to produce singlet oxygen, the maximum rate of ABMA photobleaching 
was normalised using Equation 1
17,38
 where the concentration of photosensitiser is 3 µM and 
IF431 is the fluorescence emission intensity at 431 nm. 
                                   
  
                                      
                      
           
 
The calculated maximum rates of ABMA photobleaching following irradiation are reported in 
Fig. 3b. The value obtained for the free porphyrin Na-ZnTCPP was 0.03% IF/(min·µM), while 
the Na-ZnTCPPImGNP showed a higher value of 0.11% IF/(min·µM) photobleaching. These 
results further confirm that the porphyrins are more effective for the production of singlet oxygen 
when coordinated to ImGNP. The higher production of singlet oxygen for Na-ZnTCPPImGNP 
than for the free porphyrin is remarkable considering that the photobleaching of the Na-
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ZnTCPPImGNP has been measured in an aqueous solution, where oxygen is less soluble and 
thus its lifetime is shorter.
39 
 
Fig.3. a) Percentage decay of ABMA measured at 431 nm following irradiation (400-500 
nm) of: AMBA (■ black line), Na-ZnTCPP (● red line), ImGNP (▲ green line) and Na-
ZnTCPPImGNP (◄ blue line). b) Maximum rate of ABMA photobleaching at 431 nm 
following a 1 h irradiation period, after normalisation of the porphyrin concentration. 
 
3.3. In vitro experiments using SK-BR-3 breast cancer cells 
The cytotoxic and phototoxic effects of Na-ZnTCPPImGNP when the nanoparticles were 
used to treat SK-BR-3 human breast adenocarcinoma cells were evaluated. The CellTiter-Blue® 
cell viability assay has been used and recommended to test the cytotoxicity of gold 
nanoparticles.
40,41
 SK-BR-3 cells were treated with Na-ZnTCPPImGNP at two different 
concentrations of incorporated porphyrin (1.5 μM and 1.75 μM), for 3 h. Following incubation, 
the cells were washed and irradiated at three different irradiation times ie. 10, 20 and 30 min, 
using a light source of 400 and 500 nm with a power of 2.54 mW/cm
2
. 
Cell viability was measured 48 h after PDT treatment, and the results are shown in Fig. 4. 
When the control cells with no nanoparticles loaded were irradiated during 30 min, the viability 
  
 22 
remained high (ca. 99%), indicating non-toxicity due to the irradiation with the light source. 
Following incubation with Na-ZnTCPPImGNP at either 1.5 μM (Fig. 4 a) or 1.75 μM (Fig. 4 b) 
of incorporated photosensitiser, low dark toxicity was observed as the viability of the non-
irradiated cells remained at ca. 100% and 90%, respectively. Following irradiation, the viability 
of the SK-BR-3 cells treated with Na-ZnTCPPImGNP decreased. This decrease was 
concomitant with the increase in the concentration of the photosensitiser as well as with the 
increase in the irradiation time that the cells were subjected to. Cell death was higher (> 60%) at 
all of the irradiation times used, when the cells were incubated with 1.75 μM Na-
ZnTCPPImGNP. Superior results were obtained when the cells were incubated with 1.75 μM 
(incorporated porphyrin) Na-ZnTCPPImGNP and subjected to a 30 min irradiation period, 
reaching cell death values of over 80%. These results confirm that the Na-ZnTCPPImGNP 
synthesised in this study are good candidates for PDT as they induce cell death only following 
activation with a blue light source. 
Reports in the literature present different models of studies of PDT applied with 
photosensitisers coupled to nanoparticles.
11,42,43
 The main results are studies conducted in 
different cancer cell-lines, varying irradiation time, doses of light and concentration of the 
photosensitiser.
44–46
 Most of these studies suggest that there is a percentage of cell death equal or 
higher to 90% after having received PDT. Similar results were obtained in this work using SK-
BR-3 cells treated with Na-ZnTCPPImGNP and using lower doses of light. 
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Fig. 4. CellTiter-Blue® cell viability assay results of SK-BR-3 cells incubated with Na-
ZnTCPPImGNP at either a) 1.5 µM or b) 1.75 µM of incorporated porphyrin Na-ZnTCPP. 
Cells were either irradiated with a blue light source (400-500 nm, dark cyan columns) or non-
irradiated (blue columns). The irradiated cells were irradiated for 10 (i), 20 (ii) or 30 (iii) min. 
Control cells without Na-ZnTCPPImGNP loaded were treated with FBS-free, phenol red-free 
McCOY’s 5A medium during the 3 h incubation period and only irradiated for 30 min (iii). The 
sample +ve St refers to Staurosporine, a positive control for cytotoxicity. Error bars represent the 
standard deviation with a 95% confidence interval, n=3. 
 
3.4. Cellular uptake and phototoxicity of Na-ZnTCPPImGNP in SK-BR-3 breast cancer 
cells using fluorescence microscopy 
Internalisation and phototoxicity of Na-ZnTCPPImGNP at a concentration of 1.75 µM of 
incorporated porphyrin were studied in SK-BR-3 breast cancer cells using fluorescence 
microscopy. The samples were excited at 530-585 nm and the fluorescence emission due to the 
internalised Na-ZnTCPImGNP was collected in the red channel through a 600 nm long-pass 
filter. Cells incubated with the Na-ZnTCPPImGNP (1.75 μM) for 3 h exhibited a strong 
intracellular fluorescence due to the Na-ZnTCPP, indicating the uptake of the nanoparticles by 
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the SK-BR-3 cells as shown in Fig. S11a-c. On the other hand, control cells only treated with 
FBS-free, phenol red-free McCOY’s 5A medium showed no fluorescence as shown in Fig. 
S11d-f. The images in Fig. S11 clearly demonstrate the cellular uptake of the Na-
ZnTCPPImGNP by the SK-BR-3 breast cancer cell line. Furthermore, cells imaged after being 
treated with Na-ZnTCPPImGNP or corresponding media for 3 h and then incubated for a 
longer period of time (ca. 72 h) also exhibited similar aspect, as seen in Fig. 5, with no apparent 
morphological changes and therefore, no signs of toxicity in darkness. 
 
Fig. 5. Brightfield and fluorescence images of non-irradiated SK-BR-3 cells: a)-c) loaded with 
1.75 μM Na-ZnTCPPImGNP and d)-f) control without nanoparticles loaded. The cells were 
treated with Na-ZnTCPPImGNP or corresponding media for 3 h and then incubated for 72 h 
prior to imaging. Images correspond to: a) and d) brightfield images; b) and e) fluorescence 
images due to the fluorescence of the porphyrin on the Na-ZnTCPPImGNP; and c) and f) 
composite images of brightfield and fluorescence. The samples were excited at 530-585 nm and 
the fluorescence emission was collected in the red channel through a 600 nm long-pass filter. 
Scale bars = 20 µm. 
  
 25 
To study the phototoxicity of the nanoparticles, SK-BR-3 cells were treated with Na-
ZnTCPPImGNP (1.75 μM of Na-ZnTCPP), irradiated with a blue light source (400-500 nm) 
for 30 min to induce singlet oxygen production, and incubated for ca. 72 h prior to imaging. 
Changes in the cell morphology of the treated cells were observed (Fig. 6a-c), which were not 
seen in control cells irradiated for 30 min but not loaded with nanoparticles (Fig. 6d-f). 
Furthermore, the distribution of the nanoparticles within the cells seems to be different for the 
irradiated cells (Fig. 6b) as compared to non-irradiated cells that had been treated with Na-
ZnTCPPImGNP for 3 h and incubated for 72 h prior to imaging (Fig. 5). The nanoparticles 
seem to move towards the nucleus of the dead cells following PDT. 
To confirm the cell death of those SK-BR-3 cells incubated with Na-ZnTCPPImGNP and 
irradiated with a 400-500 nm light source for 30 min, the dead cell marker propidium iodide was 
added to the samples and the cells imaged using the fluorescence microscope. Propidium iodide 
is cell-impermeable thus it can only intercalate with the DNA in the nucleus of those cells where 
the membrane has been damaged.
47
 Therefore, propidium iodide can stain dead cells.
48
 As shown 
in Fig. 6g-i, high fluorescence emission from the nucleus of the cells incubated with the Na-
ZnTCPPImGNP and irradiated to induce production of singlet oxygen was observed in the red 
channel. Control cells, without Na-ZnTCPPImGNP loaded and irradiated with a 400-500 nm 
light source for 30 min, did not exhibit fluorescence emission in the red channel (Fig. 6j-l) due to 
the propidium iodide. Furthermore, the intensity of the red fluorescence after addition of 
propidium iodide (Fig. 6h) is significantly higher than prior to addition (Fig. 6b), indicating 
positive propidium iodide staining. Additionally, as previously mentioned, changes in the cell 
morphology suggest that the SK-BR3 cells loaded with Na-ZnTCPPImGNP experienced PDT-
induced cell death, a result in agreement with the cell viability assay reported in Fig. 4.  
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Fig. 6. Brightfield and fluorescence images of SK-BR-3 cells either incubated with 1.75 μM Na-
ZnTCPPImGNP (a)-c) and g)-i)) or not incubated with nanoparticles (d)-e) and j)–l)) for 3 h. 
The cells were irradiated with a light source (400-500 nm) for 30 min and incubated for 72 h 
prior to imaging. Additionally, following the 72 h incubation period, propidium iodide was 
added to the cells to stain the nucleus of dead cells (g)-l)). Images correspond to brightfield 
images a), d), g) and j), fluorescence images due to the fluorescence of the porphyrin on the 
nanoparticles b), e), h) and k), fluorescence images due to the fluorescence of the porphyrin in 
the Na-ZnTCPPImGNP together with the fluorescence from propidium iodide h) and k) and 
composite images of brightfield and fluorescence c), f), i) and l). The samples were excited at 
530-585 nm and the fluorescence emission was collected in the red channel through a 600 nm 
long-pass filter. Scale bars = 20 µm. 
a) b) c)
d) e) f)
h)g) i)
j) k) l)
  
 27 
 
4. Conclusions 
 
In this work, we have successfully synthesised and characterised gold nanoparticles 
incorporating a tetracarboxyphenyl porphyrin linked through coordination to an imidazole 
connector, Na-ZnTCPPImGNP, and their PDT properties have been evaluated. The new 
approach described is elegant in its simplicity, using a stable coordinate bond, rather than the 
more usual covalent bonds for the incorporation of porphyrins to the gold surface.
11,18
 As far as 
we know, only one example of metalloporphyrins coordinated to gold nanoparticles had been 
reported,
19
 but the so-obtained nanosystem was neither water soluble nor were their PDT 
properties explored.  HRTEM was used to characterise the morphology of GNP as well as their 
size. This analysis showed GNP with a cubeoctahedron shape, low polydispersity and with an 
average size of 8 nm. UV-visible absorption spectroscopy and HRTEM enabled the calculation 
of the number of molecules of porphyrin incorporated per GNP resulting in 106 molecules of 
Na-ZnTCPP per nanoparticle. 
Na-ZnTCPPImGNP were able to produce singlet oxygen in a higher amount than the free 
porphyrin Na-ZnTCPP in solution, confirming previous observations for similar systems,
12,17 
a 
synergistic effect between gold and the immobilized photosensitizer. The maximum rate of 
singlet oxygen production for the free porphyrin Na-ZnTCPP was of 0.03%, while it increased 
to 0.11% when Na-ZnTCPP was incorporated in the Na-ZnTCPPImGNP.  
Finally, Na-ZnTCPPImGNP were tested in vitro to evaluate their PDT efficacy in SK-BR-3 
human breast adenocarcinoma cells. The Na-ZnTCPPImGNP were internalised by the SK-BR-
3 cells following an incubation period of only 3 h. Additionally, following irradiation with a blue 
light source of a wavelength between 400-500 nm, cell death was induced by the Na-
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ZnTCPPImGNP. Cell death was dependent on both the concentration of the porphyrin and 
irradiation time, and higher phototoxicity was observed when cells were incubated with 1.75 µM 
of incorporated porphyrin in Na-ZnTCPPImGNP and irradiated for 30 min, which led to over 
80% cell death using lower doses of light than the ones generally reported in the literature. Cell 
death was clearly visualised using fluorescence microscopy by the drastic changes in cell 
morphology as well as the positive staining of the cells with the cell death marker propidium 
iodide. The biological assays performed have demonstrated significant potential of the designed 
system as a theranostic agent at the boundary of optical imaging and PDT. The next step in this 
research may include the incorporation of targeting agents, such as antibodies, through 
immobilisation using the HS-C11-(EG)6-OH present on the Na-ZnTCPPImGNP, to specifically 
target cancer cells.  
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